Cargando…
Targeting SHIP1 and SHIP2 in Cancer
SIMPLE SUMMARY: Phosphoinositol signaling pathways and their dysregulation have been shown to have a fundamental role in health and disease, respectively. The SH2-containing 5′ inositol phosphatases, SHIP1 and SHIP2, are regulators of the PI3K/AKT pathway that have crucial roles in cancer progressio...
Autores principales: | Pedicone, Chiara, Meyer, Shea T., Chisholm, John D., Kerr, William G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924360/ https://www.ncbi.nlm.nih.gov/pubmed/33672717 http://dx.doi.org/10.3390/cancers13040890 |
Ejemplares similares
-
LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 Agonism
por: Sudan, Raki, et al.
Publicado: (2022) -
Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microglia
por: Pedicone, Chiara, et al.
Publicado: (2022) -
Obesity control by SHIP inhibition requires pan-paralog inhibition and an intact eosinophil compartment
por: Fernandes, Sandra, et al.
Publicado: (2023) -
N1-Benzyl Tryptamine Pan-SHIP1/2 Inhibitors: Synthesis and Preliminary Biological Evaluation as Anti-Tumor Agents
por: Fernandes, Sandra, et al.
Publicado: (2022) -
Targeting SHIP-1 in Myeloid Cells Enhances Trained Immunity and Boosts Response to Infection
por: Saz-Leal, Paula, et al.
Publicado: (2018)